NASDAQ : GDRX

GoodRx Holdings, Inc.

$3.14 USD

$0.02 (0.64%)

Volume
1.51M
Average Volume
1.47M
Market Capitalization
$1.09B
P/E Ratio
53.58
Dividend Yield
0.00%
Price Target
$3.00
Year High
$5.81
Year Low
$1.77
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$1.47
Company Overview

NASDAQ

Wendy Barnes

Medical - Healthcare Information Services

Healthcare

GDRX

697

US

USD

https://www.goodrx.com

855 268 2822

38246G108

0001809519

Liquidity Metrics

0.87

1.47

1.47

0.27

0.00

Sales & Valuation

$796.85M

1.38

1.72

11.27

0.28

Profitability

$0.0853

$30.44M

2.61%

5.78%

3.31%

1.02%

P/E Metrics

53.58

-1.29

-1.29

Analyst Price Target & Rating

$3.00

$3.50

$2.75

Neutral

3/5

24 Analysts

4.67%

Poll Results

About GoodRx Holdings, Inc. (NASDAQ:GDRX) Stock

GoodRx Holdings, Inc. provides American consumers with essential resources and tools to compare and ultimately lower the cost of their prescription medications. The company operates a digital platform dedicated to price comparison, delivering customized, geographically tailored prescription pricing. It also grants access to special, negotiated rates through unique GoodRx codes, which can be utilized for savings on prescriptions throughout the entire United States. Beyond this core offering, the firm also extends its portfolio to include subscription services, programs designed for pharmaceutical manufacturers, and telehealth capabilities. GoodRx additionally collaborates with pharmacy benefit managers, entities responsible for managing drug formularies and overseeing prescription transacti ... ons, including the critical task of setting prices between consumers and pharmacies. The company was founded in 2015 and maintains its principal office in Santa Monica, California.

GoodRx Announces Date for Second Quarter 2026 Earnings Release and Conference Call

2026-07-09 16:05:00

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for prescription savings in the U.S., today announced it will release its second quarter 2026 financial results after U.S. markets close on Wednesday, August 5, 2026. GoodRx management will also hold a conference call and webcast the following morning, Thursday, August 6, 2026 at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company's bus.

GoodRx (GDRX) Upgraded to Buy: What Does It Mean for the Stock?

2026-07-08 13:01:11

GoodRx (GDRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

GDRX or HQY: Which Is the Better Value Stock Right Now?

2026-07-08 12:41:04

Investors interested in Medical Services stocks are likely familiar with GoodRx Holdings, Inc. (GDRX) and HealthEquity (HQY). But which of these two stocks offers value investors a better bang for their buck right now?

Is GoodRx (GDRX) Stock Undervalued Right Now?

2026-07-08 10:41:08

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

GoodRx Launches GoodRx Companion, a New Subscription Designed to Lower Everyday Healthcare Costs

2026-05-27 10:01:00

GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today launched [url="]GoodRx Companion[/url], a new $14.99-per-month subscrip

GoodRx Launches GoodRx Companion, a New Subscription Designed to Lower Everyday Healthcare Costs

2026-05-27 09:00:00

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today launched GoodRx Companion, a new $14.99-per-month subscription that brings together free and low-cost generic medications, affordable online care visits, and savings on additional healthcare services in one simple program. Built for a healthcare environment where consumers are increasingly shouldering more out-of-pocket costs, even when they have insurance, Companion tu.

3 Reasons Retirees Should Reconsider Enrolling in a Standalone Medicare Drug Plan in 2026

2026-05-26 09:39:16

You turn 65, sign up for Medicare, and a wall of mail arrives pushing standalone Part D drug plans. The default move for decades has been to pick one and forget it. For 2026, that default deserves a fresh look. The Inflation Reduction Act fully kicks in this year, premiums and surcharges shift, and bundled... 3 Reasons Retirees Should Reconsider Enrolling in a Standalone Medicare Drug Plan in 2026

GoodRx: TrumpRx Exposes Legacy Moat Breach And Zero-Sum Strategy (Downgrade)

2026-05-20 11:46:57

GoodRx Holdings, Inc. faces ongoing revenue and margin pressure as its legacy business declines and Pharma Direct grows but with lower profitability. GDRX's Q1 results showed a 4% Y/Y revenue drop and EBITDA margin compression to 18.5%, with management expecting continued legacy erosion through 2026. Valuation sensitivity is highest to margin assumptions; the base DCF value is $2.49/share, near the current price, with scenario analysis skewed toward downside risk.

Frequently Asked Questions

What is the current GoodRx Holdings, Inc. (GDRX) stock price?

GoodRx Holdings, Inc.(NASDAQ:GDRX) stock price is $3.14 in the last trading session. During the trading session, GDRX stock reached the peak price of $5.81 while $1.77 was the lowest point it dropped to. The percentage change in GDRX stock occurred in the recent session was 0.64% while the dollar amount for the price change in GDRX stock was $0.02.

GDRX's industry and sector of operation?

The NASDAQ listed GDRX is part of Medical - Healthcare Information Services industry that operates in the broader Healthcare sector.

Who are the executives of GDRX?

Vina Leite | Chief People Officer
Scott Paul | Senior Vice President of Healthcare & Consumer Innovation
Aubrey Reynolds | Director of Investor Relations
Douglas Joseph Hirsch | Co-founder & Director
Thomas Chan | Chief Accounting Officer & Principal Accounting

How many employees does GDRX have?

Number of GDRX employees currently stands at 697. GDRX operates from 2701 Olympic Boulevard, Santa Monica, CA 90404, US.

Link for GDRX official website?

Official Website of GDRX is: https://www.goodrx.com

How do I contact GDRX?

GDRX could be contacted at phone #855 268 2822 and can also be accessed through its website. GDRX operates from 2701 Olympic Boulevard, Santa Monica, CA 90404, US.

How many shares of GDRX are traded daily?

The average number of GDRX shares traded daily for last 3 months was 1.47M.

What is the market cap of GDRX currently?

The market value of GDRX currently stands at $1.09B with its latest stock price at $3.14